For patients using GLP-1 medications for type 2 diabetes, hemoglobin A1c may increase after discontinuation if no alternative therapy is initiated, with the magnitude varying based on individual factors and baseline therapy
They find that patients spend approximately $1,000 on GLP-1s in their initiation month, but many discontinue treatment within the first few months
These nanosystems offer a transformative platform for enhancing the pharmacological and biopharmaceutical performance of various drugs, including GLP-1 receptor agonists, which are otherwise limited by poor oral bioavailability, enzymatic degradation, and rapid renal clearance
Clinical research has shown that Retatrutide produces significant body weight reduction, with Phase 2 trial participants achieving up to 24% weight loss over 48 weeks
In the longer term, reduced obesity rates among Medicaid enrollees could also result in reduced Medicaid spending on chronic diseases associated with obesity, though the evidence is mixed